Literature DB >> 5428437

Inhibition of rodent malaria in mice by rifampicin.

N E Alger, D T Spira, P H Silverman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5428437     DOI： 10.1038/227381b0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

1.  The action of metabolic inhibitors on microgametogenesis in Plasmodium yoelii nigeriensis.

Authors:  P J Toyé; R E Sinden; E U Canning
Journal:  Z Parasitenkd       Date:  1977-09-21

2.  Influence of 9-beta-D-arabinofuranosyladenine on total protein synthesis and on differential gene expression of unique proteins in the rodent malarial parasite Plasmodium berghei.

Authors:  J Ilan; D R Pierce; F W Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

3.  Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria.

Authors:  S Pukrittayakamee; S Prakongpan; S Wanwimolruk; R Clemens; S Looareesuwan; N J White
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

4.  Assessment of in vivo antimalarial activity of rifampicin, isoniazide, and ethambutol combination therapy.

Authors:  Nayak P Aditya; Swati Patankar; Basavaraj Madhusudhan
Journal:  Parasitol Res       Date:  2010-02-18       Impact factor: 2.289

5.  Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture.

Authors:  A A Divo; T G Geary; J B Jensen
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

6.  Rifampicin/Cotrimoxazole/Isoniazid versus mefloquine or quinine + sulfadoxine- pyrimethamine for malaria: a randomized trial.

Authors:  Blaise Genton; Ivo Mueller; Inoni Betuela; Gerard Casey; Meza Ginny; Michael P Alpers; John C Reeder
Journal:  PLoS Clin Trials       Date:  2006-12-22

7.  Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.

Authors:  Marcel Kaiser; Pascal Mäser; Leela Pavan Tadoori; Jean-Robert Ioset; Reto Brun
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

8.  Antimalarial effects of rifampin in Plasmodium vivax malaria.

Authors:  S Pukrittayakamee; C Viravan; P Charoenlarp; C Yeamput; R J Wilson; N J White
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

9.  Interaction between rifampicin, amodiaquine and artemether in mice infected with chloroquine resistant Plasmodium berghei.

Authors:  Joseph A Badejo; Oyindamola O Abiodun; Olugbenga Akinola; Christian T Happi; Akintunde Sowunmi; Grace O Gbotosho
Journal:  Malar J       Date:  2014-08-05       Impact factor: 2.979

Review 10.  Repurposing Drugs to Fight Hepatic Malaria Parasites.

Authors:  Diana Fontinha; Isabel Moules; Miguel Prudêncio
Journal:  Molecules       Date:  2020-07-28       Impact factor: 4.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.